HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neutrogena Enters Naturals Fray With Bio-Nutrient-Driven Skin Care

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson is taking its venerable Neutrogena skin-care brand into the naturals segment with the launch of a full range of products that “harness the power of naturally occurring bio-nutrients,” the firm announces.

You may also be interested in...



J&J Settles Class Action For “Misleading” Neutrogena Naturals Claims

Johnson & Johnson has agreed to settle a class-action suit alleging that despite “natural” claims, Neutrogena Naturals skin-care products contain petrochemicals and “various artificial and synthetic ingredients.” J&J will specify natural content on the front panel of product packaging and continue to have “open and honest conversations” with its natural customers about product content, the firm says.

J&J Extends Delay In Returning Some OTCs To Market

CFO Caruso says operating under a consent decree with “a third party in the manufacturing facilities with us” makes it “very difficult for us to predict exactly when products will return.” Some products will not return to stores until 2013, significantly later than the original goal to relaunch all recalled liquid OTCs before 2012.

J&J Extends Delay In Returning Some OTCs To Market

CFO Caruso says operating under a consent decree with “a third party in the manufacturing facilities with us” makes it “very difficult for us to predict exactly when products will return.” Some products will not return to stores until 2013, significantly later than the original goal to relaunch all recalled liquid OTCs before 2012.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017558

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel